Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Edwards Lifesciences beats profit estimate on strength in heart devices
04:19pm, Tuesday, 11'th Feb 2025
Edwards Lifesciences beat analysts' estimate for fourth-quarter profit on Tuesday, helped by strong demand for its artificial heart valves and other medical devices.
Edwards Lifesciences Reports Fourth Quarter Results
04:15pm, Tuesday, 11'th Feb 2025
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024. Highlights and Outlook Q4 sales grew 9% to $1.39 bi
Insights Into Edwards Lifesciences (EW) Q4: Wall Street Projections for Key Metrics
10:21am, Thursday, 06'th Feb 2025
Besides Wall Street's top -and-bottom-line estimates for Edwards Lifesciences (EW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared du
ITGR or EW: Which Is the Better Value Stock Right Now?
12:40pm, Tuesday, 04'th Feb 2025
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integer (ITGR) and Edwards Lifesciences (EW). But which of these two stocks is more attractive to va
Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025
07:05am, Tuesday, 04'th Feb 2025
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2024 after the market closes on Tuesday February 11, 2025, a
Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion
02:21pm, Thursday, 30'th Jan 2025
Edwards Lifesciences Corporation EW shares are trading higher on Thursday.
Edwards Lifesciences Q4 Earnings Set to Benefit From TAVR Growth
11:25am, Thursday, 30'th Jan 2025
Favorable hospitalization trend, strong adoption of transcatheter heart valves and improved procedural volume are expected to have aided EW in the fourth quarter.
Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for
11:06am, Tuesday, 28'th Jan 2025
Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Edwards Lifesciences Stock Stay in Your Portfolio Now?
08:25am, Thursday, 16'th Jan 2025
EW stock is on investors' radar courtesy to the promising structural heart opportunities post the divestment of the Critical Care arm.
Wedgewood Partners: Q4 And 2024 Top Performers And Detractors
08:00am, Thursday, 16'th Jan 2025
Texas Pacific Land and Taiwan Semiconductor Manufacturing were top contributors for both the quarter and the year, showcasing strong earnings growth and strategic market positioning. Despite Texas Pac
Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07:05am, Tuesday, 07'th Jan 2025
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025. Bernard Zovighian,
4 Strong Stock Charts For 2025 (Technical Analysis)
12:00pm, Monday, 30'th Dec 2024
After analyzing weekly charts of all S&P 500 stocks, I found only 21 with “confidently optimistic” patterns, indicating a challenging market in 2025. My focus is on stocks with better odds of appr
Is the Options Market Predicting a Spike in Edwards (EW) Stock?
10:00am, Friday, 20'th Dec 2024
Investors need to pay close attention to Edwards (EW) stock based on the movements in the options market lately.
NEW YORK, NY / ACCESSWIRE / December 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal secu
NEW YORK, NY / ACCESSWIRE / December 13, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal secu
